Please select the option that best describes you:
Would history of breast cancer deter you from using ospemifene for severe vaginal dryness/dyspareunia?
Does the type of breast cancer factor into your decision making?
Answer from: Medical Oncologist at Academic Institution
The agonistic/antagonistic activity of ospemifene in different tissues that express estrogen receptors is incompletely understood and therefore, I would have reservations about using this agent in women with hormone receptor positive breast cancer. In fact, looking at the labeling information of osp...
Sign in or Register to read more